secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monte Rosa Therapeutics, Inc. (GLUE)
CIK:        0001826457
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0000950170-25-086129
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Monte Rosa Therapeutics elects three Class I directors, ratifies auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Elected Christine Siu, Kimberly Blackwell, and Jan Skvarka as Class I directors for three-year terms ending in 2028.
- Christine Siu received 52.1M for, 3.4M withheld; Jan Skvarka received 44.8M for, 10.7M withheld.
- Ratified Deloitte & Touche LLP as independent auditor for FY 2025 with 57.9M for, 139k against, 12.9k abstain.
- Record date April 16, 2025; 61,509,821 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826457/000095017025086129/0000950170-25-086129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826457/000095017025086129/glue-20250613.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer